Clinic Promote Ltd Filleted Accounts Cover
Clinic Promote Ltd
Company No. 11808319
Information for Filing with The Registrar
28 February 2023
Clinic Promote Ltd Directors Report Registrar
The Director presents his report and the accounts for the year ended 28 February 2023.
Principal activities
The principal activity of the company during the year under review was information technology consultancy.
Director
The Director who served at any time during the year was as follows:
A.M. Gove
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
A.M. Gove
Director
24 November 2023
Clinic Promote Ltd Balance Sheet Registrar
at
28 February 2023
Company No.
11808319
Notes
2023
2022
£
£
Current assets
Debtors
4
5050
Cash at bank and in hand
8021,727
8521,777
Creditors: Amount falling due within one year
5
(17,244)
(6,243)
Net current liabilities
(16,392)
(4,466)
Total assets less current liabilities
(16,392)
(4,466)
Net liabilities
(16,392)
(4,466)
Capital and reserves
Called up share capital
100100
Profit and loss account
7
(16,492)
(4,566)
Total equity
(16,392)
(4,466)
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 24 November 2023 and signed on its behalf by:
A.M. Gove
Director
24 November 2023
Clinic Promote Ltd Notes to the Accounts Registrar
for the year ended 28 February 2023
1
General information
Clinic Promote Ltd is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 11808319
Its registered office is:
Walden House
Foxcombe Road
Oxford
OX1 5DL
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Going concern
At the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the forseeable future. Thus, the director continues to adopt the going concern basis of accounting in preparing the financial statements.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Research and development costs
Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the balance sheet.
3
Employees
2023
2022
Number
Number
The average monthly number of employees (including directors) during the year was:
11
4
Debtors
2023
2022
£
£
Trade debtors
5050
5050
5
Creditors:
amounts falling due within one year
2023
2022
£
£
Loans from directors
16,7455,745
Accruals and deferred income
499498
17,2446,243
6
Share Capital
£1 x £100 Ordinary Shares called up and fully paid.
7
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
Clinic Promote Ltd1180831928 February 202301 March 2022false24 November 2023BTCSoftware AP Solution 2023 10.4.0310.4.03true118083192022-03-012023-02-28118083192023-02-28118083192022-02-2811808319core:WithinOneYear2023-02-2811808319core:WithinOneYear2022-02-2811808319core:ShareCapital2023-02-2811808319core:ShareCapital2022-02-2811808319core:RetainedEarningsAccumulatedLosses2023-02-2811808319core:RetainedEarningsAccumulatedLosses2022-02-2811808319countries:UnitedKingdom2022-03-012023-02-2811808319bus:RegisteredOffice2022-03-012023-02-28118083192021-03-012022-02-2811808319core:RetainedEarningsAccumulatedLosses2022-03-012023-02-28118083192022-03-0111808319bus:SmallEntities2022-03-012023-02-2811808319bus:FullAccounts2022-03-012023-02-2811808319bus:AuditExempt-NoAccountantsReport2022-03-012023-02-2811808319bus:Director12022-03-012023-02-2811808319bus:PrivateLimitedCompanyLtd2022-03-012023-02-28iso4217:GBPxbrli:pure